Supernus Pharmaceuticals (SUPN) Debt to Equity (2011 - 2025)
Supernus Pharmaceuticals (SUPN) reported Debt to Equity of $0.03 for Q4 2025, down 36.01% year-over-year from $0.05 in Q4 2024, and up 173.25% quarter-over-quarter from $0.01 in Q3 2025.
Supernus Pharmaceuticals (SUPN) Debt to Equity (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 9 years of Debt to Equity data on file, last reported at $0.03 in Q4 2025.
- Debt to Equity for Q4 2025 came in at $0.03, down 36.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.03 (down 36.01% YoY), and the FY2025 annual result was $0.03, down 36.01% from the prior year.
- Debt to Equity improved to $0.03 in Q4 2025 per SUPN's latest filing, from $0.01 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.52 in Q4 2021 and troughed at $0.01 in Q3 2025.
- A 5-year average of $0.09 and a median of $0.05 in 2024 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 1490.04% in 2022 and fell as far as 95.42% in 2022.
- A 5-year view of Debt to Equity shows it stood at $0.52 in 2021, then tumbled by 95.42% to $0.02 in 2022, then jumped by 137.1% to $0.06 in 2023, then decreased by 19.11% to $0.05 in 2024, then tumbled by 36.01% to $0.03 in 2025.
- Business Quant data shows SUPN's Debt to Equity at $0.03 in Q4 2025, $0.01 in Q3 2025, and $0.03 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.86 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.47 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.48 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.03 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.04 |
| Sep 30, 2020 | 0.12 |